Global Transcriptomics Technologies Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Transcriptomics Technologies Market was valued at $8.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.8% CAGR, to an estimated market size of $13.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global transcriptomics technologies market includes the platforms, reagents, and bioinformatics tools used to study the transcriptome, which is the complete set of RNA transcripts in a cell. The scope covers Next-Generation Sequencing (NGS), microarrays, and PCR technologies used for gene expression profiling, drug discovery, and clinical diagnostics, while excluding general genomic sequencing not focused on RNA analysis.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Transcriptomics Technologies Market in the period 2025-30:
- The market is rapidly transitioning from bulk RNA-Seq to single-cell transcriptomics to better understand cellular heterogeneity in complex diseases.
- Integration of Artificial Intelligence and machine learning is significantly reducing the time required for complex transcriptomic data interpretation and biomarker discovery.
- The emergence of spatial transcriptomics is allowing researchers to map gene expression within the original structural context of tissue samples.
- A strategic shift toward multi-omics platforms is enabling the simultaneous analysis of RNA, DNA, and proteins for a holistic view of biological systems.
- Plummeting costs of high-throughput sequencing are democratizing access to transcriptomic tools for smaller research laboratories and clinical settings.
- Increasing clinical adoption of liquid biopsy platforms is utilizing circulating RNA for real-time, non-invasive disease monitoring in oncology.
- Rising demand for personalized medicine is driving the use of transcriptomic profiling to predict individual patient responses to specific therapeutic agents.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarrays
- Other Technologies